Case Report
Prophylactic Use of Fentanyl Buccal Tablets for Predictable Breakthrough Pain: A Case Report
Iwao Osaka*, Shigeki Ono, Akinori Aikawa, Akira Kimura, Yoshie Shizusawa and Isamu AdachiDivision of Palliative Medicine, Shizuoka Cancer Center Hospital, Japan
- *Corresponding Author:
- Iwao Osaka
Division of Palliative Medicine
Shizuoka Cancer Center Hospital
1007 Shimonagakubo, Nagaizumicho
Sunto-gun, Shizuoka,411-8777 Japan
Tel: +81-55-989-5222
E-mail: i.osaka@scchr.jp
Received date: September 01, 2014; Accepted date: September 22, 2014; Published date: September 30, 2014
Citation: Osaka I, Ono S, Aikawa A, Kimura A, Shizusawa Y, et al. (2014) Prophylactic Use of Fentanyl Buccal Tablets for Predictable Breakthrough Pain: A Case Report. J Palliat Care Med 4:191. doi:10.4172/2165-7386.1000191
Copyright: © 2014 Osaka I, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Short acting opioids, such as morphine, are recommended for the management of predictable breakthrough pain in cancer patients. However, it has been reported that prophylactic fentanyl rescue medication, which is more effective and has a shorter duration of action, is more suitable for some patients depending on their symptoms and the characteristics of their breakthrough pain. Herein, we report the case of a 68-year-old man with prostate cancer who received high-quality analgesic treatment by prophylactic administration of fentanyl buccal tablets before meals. It is hoped that fentanyl rescue medication can be used as a prophylactic for predictable breakthrough pain in other cancer patients.
